Back
BeiGene Vs. Theravance Biopharma Industry Stock Comparison
Sell
27
BGNE
BeiGene
Last Price:
144.34
Seasonality Move:
18.09%
Sell
37
TBPH
Theravance Biopharma
Last Price:
9.17
Seasonality Move:
-13.53%
Sell
27
BeiGene (BGNE)
is a Sell
Is BeiGene a Buy, Sell or Hold?
- The current BeiGene [BGNE] share price is $138.99. The Score for BGNE is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- BGNE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Theravance Biopharma (TBPH)
is a Sell
Is Theravance Biopharma a Buy, Sell or Hold?
- The current Theravance Biopharma [TBPH] share price is $9.21. The Score for TBPH is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- TBPH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BGNE Stock Price Chart
TBPH Stock Price Chart
What is Theravance Biopharma's stock price today?
-
The Theravance Biopharma share price today is $9.21
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TBPH is experiencing selling pressure, which indicates risk of future bearish movement.
BGNE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -7.02 | Sell |
Relative Strength Index (14 RSI): | 41.45 | Sell |
Chaikin Money Flow: | 27615 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (137.37 - 159.63) | Sell |
Bollinger Bands (100): | (147.38 - 177.44) | Sell |
TBPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.1 | Buy |
Relative Strength Index (14 RSI): | 49.13 | Sell |
Chaikin Money Flow: | -255012 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.92 - 9.52) | Sell |
Bollinger Bands (100): | (8.74 - 10.56) | Sell |
BGNE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 134.63 | Buy |
20-day SMA: | 145.25 | Sell |
50-day SMA: | 154.37 | Sell |
200-day SMA: | 176.87 | Sell |
8-day EMA: | 136.36 | Buy |
20-day EMA: | 143.52 | Sell |
50-day EMA: | 152.33 | Sell |
200-day EMA: | 174.19 | Sell |
TBPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.49 | Sell |
20-day SMA: | 9.3 | Sell |
50-day SMA: | 9.03 | Buy |
200-day SMA: | 9.63 | Sell |
8-day EMA: | 9.38 | Sell |
20-day EMA: | 9.3 | Sell |
50-day EMA: | 9.25 | Sell |
200-day EMA: | 9.67 | Sell |
BeiGene Earnings Growth & BGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.91 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and an increase next year of $4.90 per share.
Theravance Biopharma Earnings Growth & TBPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $0.50 per share.
BeiGene Technical Analysis
Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Theravance Biopharma Technical Analysis
Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |